AG criticises Tender Board for $1.3 B allocation to New GPC
…cites gross irregularities
Accusing fingers are being pointed to the National Procurement and Tender Administration Board for approving the payment of an exorbitant sum to the New Guyana Pharmaceutical Corporation Limited.
According to the 2010 Auditor General Report the astronomical sum of $1.252 billion was paid to the company on the basis of sole sourcing and not by competitive bidding as required under the Procurement Act (2003).
The transactions with the firm, the Report outlines, were for the procurement of drugs and medical supplies.
This practice was also extended to the Georgetown Public Hospital Corporation (GPHC). The public hospital, the Report stated, also procured drugs and medical supplies at a cost of $879.914M based on awards of contracts by the Tender Board without a system of competitive bidding as required under the said Procurement Act. [Read more]
— Post #1106
